Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study

Clinical Therapeutics

Volumn 35, Issue 4, 2013, Pages 474-485

  Meca Lallana, Jose E ^a,b   Hernández Clares, Rocío ^a,b   León Hernández, Adelaida ^a,b   Genovés Aleixandre, Alicia ^a   Cacho Pérez, Margarita ^a   Martín Fernández, Jose J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b CATHOLIC UNIVERSITY OF MURCIA   (Spain)

Author keywords

Clinically isolated CNS demyelinating syndrome; MRI; Multiple sclerosis; Plasma exchange; Relapse

Indexed keywords

HEMOGLOBIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; DEMYELINATING DISEASE; DIPLOPIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMIPARESIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; ORTHOSTATIC HYPOTENSION; PARAPLEGIA; PILOT STUDY; PLASMAPHERESIS; PROSPECTIVE STUDY; QUADRIPLEGIA; RECURRENT DISEASE; THROMBOSIS; URINARY TRACT INFECTION; URINE CULTURE;

ADULT; AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PILOT PROJECTS; PLASMA EXCHANGE; RECURRENCE; YOUNG ADULT;

EID: 84876344892     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.02.027     Document Type: Article

References (40)

1. Beck R.W., Cleary P.A., Anderson M.M., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992, 326:581-588.
2. Durelli L., Cocito D., Riccio A., et al. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 1986, 36:238-243.
3. Noseworthy J., Confavreux C., Compson A. Treatment of the acute relapse. McAlpine's Multiple Sclerosis 2005, 683-699. Churchill Livinsgtone Elsevier, Philadelphia, Pa. 4th ed.
4. Lublin F.D., Baier M., Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003, 61:1528-1532.
5. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285.
6. Airas L., Kurki T., Erjanti H., Marttila R.J. Successful pregnancy of a patient with Balo's concentric sclerosis. Mult Scler 2005, 11:346-348.
7. Bonnan M., Valentino R., Olindo S., et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 2009, 15:487-492.
8. Brunot S., Vukusic S., Fromont A., et al. Plasma exchanges in severe and acute inflammatory demyelinating attacks of the central nervous system [article in French]. Presse Med 2011, 40:e271-e278.
9. Jacquerye P., Ossemann M., Laloux P., Dive A., De Coene B. Acute fulminant multiple sclerosis and plasma exchange. Eur Neurol 1999, 41:174-175.
10. Kanter D.S., Horensky D., Sperling R.A., et al. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995, 45:824-827.
11. Keegan M., Konig F., McClelland R., et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005, 366:579-582.
12. Llufriu S., Castillo J., Blanco Y., et al. Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months. Neurology 2009, 73:949-953.
13. Magana S.M., Keegan B.M., Weinshenker B.G., et al. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol 2011, 68:870-878.
14. Mauch E., Zwanzger J., Hettich R., et al. Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients [article in German]. Nervenarzt 2011, 82:1590-1595.
15. Meca-Lallana J.E., Rodriguez-Hilario H., Martinez-Vidal S., et al. Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study [article in Spanish]. Rev Neurol 2003, 37:917-926.
16. Munemoto M., Otaki Y., Kasama S., et al. Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis. J Clin Neurosci 2011, 18:478-480.
17. RamachandranNair R., Parameswaran M., Girija A.S. Acute disseminated encephalomyelitis treated with plasmapheresis. Singapore Med J 2005, 46:561-563.
18. Rodriguez M., Karnes W.E., Bartleson J.D., Pineda A.A. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993, 43:1100-1104.
19. Schilling S., Linker R.A., Konig F.B., et al. Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients [article in German]. Nervenarzt 2006, 77:430-438.
20. Sekijima Y., Tokuda T., Hashimoto T., et al. Serial magnetic resonance imaging (MRI) study of a patient with Balo's concentric sclerosis treated with immunoadsorption plasmapheresis. Mult Scler 1997, 2:291-294.
21. Shinozaki K., Oda S., Sadahiro T., et al. A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis. Ther Apher Dial 2008, 12:401-405.
22. Trebst C., Reising A., Kielstein J.T., et al. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 2009, 28:108-115.
23. Wang K.C., Wang S.J., Lee C.L., et al. The rescue effect of plasma exchange for neuromyelitis optica. J Clin Neurosci 2011, 18:43-46.
24. Watanabe S., Nakashima I., Misu T., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007, 13:128-132.
25. Weinshenker B.G., O'Brien P.C., Petterson T.M., et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878-886.
26. Barkhof F., Hommes O.R., Scheltens P., Valk J. Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology 1991, 41:1219-1222.
27. Smith K., McDonald I., Miller D., Lassmann H. The pathophysiology of multiple sclerosis. McAlpine's Multiple Sclerosis 2005, 601-659. Churchill Livingstone Elsevier, Philadelphia, Pa. 4th ed.
28. Mao-Draayer Y., Braff S., Pendlebury W., Panitch H. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 2002, 59:1074-1077.
29. Paus S., Promse A., Schmidt S., Klockgether T. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 2003, 61:1022.
30. Pericot I., Rio J., Rovira A., et al. Serial gadolinium-enhanced MRI in acute attack of multiple sclerosis treated with plasma exchange. J Neurol 2003, 250:243-244.
31. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria.". Ann Neurol 2005, 58:840-846.
32. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
33. Spiegel M., Kruger H., Hofmann E., Kappos L. MRI study of Balo's concentric sclerosis before and after immunosuppressive therapy. J Neurol 1989, 236:487-488.
34. Dau P.C. Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis. J Neuroimmunol 1995, 62:197-200.
35. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
36. Keegan M., Pineda A.A., McClelland R.L., et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002, 58:143-146.
37. Kreft K.L., Mellema S.J., Hintzen R.Q. Spinal cord involvement in Balo's concentric sclerosis. J Neurol. Sci 2009, 279:114-117.
38. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
39. Khurana D.S., Melvin J.J., Kothare S.V., et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005, 116:431-436.
40. Cortese I., Chaudhry V., So Y.T., et al. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011, 76:294-300.